Estradiol modulated colorectal cancer stem cells bioactivity and interaction with endothelial cells.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
15 Sep 2020
Historique:
received: 29 04 2020
revised: 01 07 2020
accepted: 07 07 2020
pubmed: 15 7 2020
medline: 18 9 2020
entrez: 15 7 2020
Statut: ppublish

Résumé

This study aimed to evaluate the modulatory role of sex-related hormone estradiol on cancer stem cells with the origin of colorectal adenocarcinoma in vitro. Cancer stem cells were incubated with 100 nM estradiol for 48 h. The cell survival rate was analyzed using the MTT assay. Immunocytochemistry staining of Ki-67 and Inhibin and Apoptosis PCR array were done to measure proliferation/apoptosis. Cell migration was monitored via the Transwell Migration assay. The expression of exosome biogenesis genes was measured using a real-time PCR assay. The fatty acid profile was monitored using gas chromatography. The level of FAK, SQSTM1, ER, and SIRT1 was examined using Western blotting. Cancer stem-endothelial cell interaction was investigated using Surface Plasmon Resonance assay. Data showed no significant differences in cancer stem cell viability and proliferation between control and estradiol-treated groups (p>0.05). PCR array highlighted the up-regulation of both pro- and anti-apoptosis effectors in the treatment group compared to the control cells (p<0.05). Cell migration capacity was increased after treatment with estradiol (p<0.001). Both exocytosis and exosome biogenesis were decreased in cancer stem cells exposed to estradiol (p<0.05). Data showed the reduction of palmitic acid, and increase of Palmitoleic and Linolenic acids in estradiol-treated cells. Estrogen induced estrogen receptor, SQSTM1 proteins and decreased SIRT1 factor after 48 h. Surface Plasmon Resonance revealed the suppression of cancer stem-endothelial cell interaction and affinity. Estradiol could change the migration, juxtacrine and paracrine activities of cancer stem cells, showing the importance of sex-related hormones in the dynamic of cancer development.

Identifiants

pubmed: 32663577
pii: S0024-3205(20)30829-8
doi: 10.1016/j.lfs.2020.118078
pii:
doi:

Substances chimiques

Receptors, Estrogen 0
Estradiol 4TI98Z838E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118078

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no competing interests.

Auteurs

Arezoo Rezaie Nezhad Zamani (ARN)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Çigir Biray Avci (ÇB)

Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey.

Mahdi Ahmadi (M)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Ayda Pouyafar (A)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Hesam Saghaei Bagheri (HS)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Farzaneh Fathi (F)

Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.

Morteza Heidarzadeh (M)

Koç University, School of Medicine, Biophysics Department, Rumeli Fener, Sarıyer, Istanbul.

Jafar Rezaie (J)

Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.

Yasaman Mirhosseini (Y)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Shirin Saberianpour (S)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Amir Mehdizadeh (A)

Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Emel Sokullu (E)

Koç University, School of Medicine, Biophysics Department, Rumeli Fener, Sarıyer, Istanbul; Koç University Research Center for Translational Medicine, KUTTAM, Rumeli Feneri Sarıyer, Istanbul, Turkey.

Mehdi Talebi (M)

Hematology And Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Reza Rahbarghazi (R)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: rahbarghazir@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH